Skip to main content
Year archive

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — 2023 filings

All 38 regulatory filings released by MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED (MVP) in 2023, sourced directly from the official regulator.

38 Filings
2023 Period
2023 filings (38)
Filing Released Lang
Notification of cessation of securities - MVP 4 pages 24.1KB
Regulatory Filings
2023-11-27 English
Notification regarding unquoted securities - MVP 7 pages 28.9KB
Regulatory Filings
2023-11-27 English
2023 Annual General Meeting Recording 1 page 685.7K
Regulatory Filings
2023-10-30 English
2023 Annual General Meeting Presentation 25 pages 4.0MB
Regulatory Filings
2023-10-26 English
2023 Annual General Meeting Chair and CEO address 4 pages 697.4KB
Regulatory Filings
2023-10-26 English
Results of Annual General Meeting 2 pages 613.2KB
Regulatory Filings
2023-10-26 English
Corporate Governance Statement 9 pages 557.7KB
Regulatory Filings
2023-09-24 English
Appendix 4G 14 pages 397.6KB
Regulatory Filings
2023-09-24 English
Annual Report to Shareholders 46 pages 8.7MB
Regulatory Filings
2023-09-24 English
Notice of Annual General Meeting and Proxy Form 29 pages 325.4KB
Regulatory Filings
2023-09-24 English
Change of Director Interests 2 pages 280.5KB
Regulatory Filings
2023-09-10 English
Date of AGM and Closing Date for Director Nominations 1
Regulatory Filings
2023-09-10 English
Update to Securities Trading Policy 9 pages 411.0KB
Regulatory Filings
2023-09-10 English
Transcript of FY23 Full Year Investor Presentation 8 pages 388.7KB
Regulatory Filings
2023-09-04 English
FY23 Full Year Accounts 59 pages 3.4MB
Regulatory Filings
2023-08-30 English
MVP Announces FY23 Full Year Results 4 pages 291.8KB
Regulatory Filings
2023-08-30 English
FY23 Full Year Results Investor Presentation 26 pages 1.9MB
Regulatory Filings
2023-08-30 English
Appointment of Director - Dr Russell Basser 1 page
Regulatory Filings
2023-08-30 English
Initial Director's Interest Notice 2 pages 250.7KB
Regulatory Filings
2023-08-30 English
Changes to CEO Remuneration and Employment Contract 3 pages 231.1KB
Regulatory Filings
2023-08-30 English
Ceasing to be a substantial holder for MVP 3 pages 154.3KB
Regulatory Filings
2023-08-27 English
FY23 Full Year Results Announcement Details 1 page
Regulatory Filings
2023-08-14 English
Application for quotation of securities - MVP 6 pages 27.7KB
Regulatory Filings
2023-08-02 English
Response to ASX Price Query 3 pages 679.7KB
Regulatory Filings
2023-07-25 English
Notification of cessation of securities - MVP 4 pages 23.8KB
Regulatory Filings
2023-07-12 English
Notification of cessation of securities - MVP 4 pages 23.8KB
Regulatory Filings
2023-07-12 English
Change in substantial holding 5 pages 276.8KB
Regulatory Filings
2023-05-14 English
Final Director's Interest Notice - D. Williams 2 pages 261.0KB
Regulatory Filings
2023-04-25 English
Resignation of Director 1 page 128.0KB
Regulatory Filings
2023-04-17 English
US Penthrox Strategy 1 page 215.1KB
Regulatory Filings
2023-04-10 English
2023 Half Year Report (including 4D) 23 pages 2.2MB
Regulatory Filings
2023-02-23 English
2023 Half Year ASX Announcement 3 pages 276.2KB
Regulatory Filings
2023-02-23 English
2023 Half Year Presentation 20 pages 3.0MB
Regulatory Filings
2023-02-23 English
Confirmation of Half Year Results Presentation Details 1
Regulatory Filings
2023-02-23 English
Half Year Results Announcement Details 1 page 93.1K
Regulatory Filings
2023-02-05 English
Notification regarding unquoted securities - MVP 7 pages 30.9KB
Regulatory Filings
2023-01-19 English
Notification of cessation of securities - MVP 4 pages 24.2KB
Regulatory Filings
2023-01-19 English
China Clinical Trials Discontinued 1 page 100.1KB
Regulatory Filings
2023-01-17 English